Q28.2 Arteriovenous malformation of cerebral vessels
The ICD-10-CM code for Arteriovenous malformation of cerebral vessels is Q28.2 (FY2026). It is a billable, claim-ready diagnosis code.
Classification
- Section
- Q20-Q28: Congenital malformations of the circulatory system (Q20-Q28)
- Category Q28
- 7 codes (6 billable)
- FY2026 Status
- Stable since FY2024
Also Known As
ICD-10-CM Alphabetic Index entries that lead to Q28.2:
- Aneurysm (anastomotic) (artery) (cirsoid) (diffuse) (false) (fusiform) (multiple) (saccular) › brain › arteriovenous (congenital) (nonruptured)
- Malformation (congenital) › arteriovenous, aneurysmatic (congenital) › cerebral
- Aneurysm (anastomotic) (artery) (cirsoid) (diffuse) (false) (fusiform) (multiple) (saccular) › arteriovenous (congenital) › brain
- Malformation (congenital) › arteriovenous, aneurysmatic (congenital) › brain
- Malformation (congenital) › brain (multiple) › arteriovenous
- Fistula (cutaneous) › arteriovenous (acquired) (nonruptured) › brain › congenital
- Fistula (cutaneous) › arteriovenous (acquired) (nonruptured) › congenital (peripheral) › brain
- Fistula (cutaneous) › brain › arteriovenous (acquired) › congenital
Inclusion Terms
- Arteriovenous malformation of brain NOS
- Congenital arteriovenous cerebral aneurysm (nonruptured)
U.S. Hospital Utilization
- An estimated 9,210 U.S. inpatient stays in 2023 included Q28.2 among the documented diagnoses.
- 2,955 stays listed it as the principal diagnosis.
Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.
Official Coding Guidelines
POA indicator for congenital conditions/anomalies and Q00-Q99 exceptionCongenital conditions and anomalies Assign “Y” for congenital conditions and anomalies except for categories Q00- Q99, Congenital anomalies, which are on the exempt list. Congenital conditions are always considered present on admission.
Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026